Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
852 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04773769 | Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas | unknown | N/A | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT00002611 | Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer | completed | Phase 3 | 3,031 | Children's Oncology GroupNETWORK | 7 | Feb 25, 2021 |
| clinicaltrials |
| NCT00585312 | Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)(CHIP) | terminated | Phase 3 | 106 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc.INDUSTRY | 14 | Feb 21, 2021 | clinicaltrials |
| NCT02910063 | Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL | completed | Phase 2 / Phase 3 | 41 | AmgenINDUSTRY | 8 | Jan 13, 2021 | clinicaltrials |
| NCT02788214 | Helicobacter Pylori Genome Project (HpGP) | terminated | — | 1,000 | National Cancer Institute (NCI)NIH | 53 | Dec 19, 2020 | clinicaltrials |
| NCT00927485 | Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP) | completed | N/A | 44 | University of Puerto RicoOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT00927680 | Familial Colorectal Cancer Registry in Hispanics(PURIFICAR) | unknown | — | 5,000 | University of Puerto RicoOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT01102426 | Aplidin - Dexamethasone in Relapsed/Refractory Myeloma(ADMYRE) | completed | Phase 3 | 255 | PharmaMarINDUSTRY | 19 | Nov 10, 2020 | clinicaltrials |
| NCT04617236 | Cultivando la Salud: A Breast and Cervical Cancer Screening Promotion Program for Low-Income Puerto Rican Women(CLS) | completed | N/A | 444 | University of Puerto RicoOTHER | 1 | Nov 5, 2020 | clinicaltrials |
| NCT00030654 | Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 21 | Radiation Therapy Oncology GroupNETWORK | 4 | Oct 22, 2020 | clinicaltrials |
| NCT01362179 | National Marrow Donor Program Long-Term Donor Follow-Up(LTDFU) | completed | — | 21,974 | Center for International Blood and Marrow Transplant ResearchNETWORK | 2 | Oct 20, 2020 | clinicaltrials |
| NCT01209325 | Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | completed | Phase 2 | 149 | AIDS Malignancy ConsortiumNETWORK | 2 | Aug 11, 2020 | clinicaltrials |
| NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | completed | Phase 2 | 117 | Eli Lilly and CompanyINDUSTRY | 6 | Jul 21, 2020 | clinicaltrials |
| NCT00003594 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 3 | 1,691 | Alliance for Clinical Trials in OncologyOTHER | 4 | Apr 29, 2020 | clinicaltrials |
| NCT00720109 | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | Phase 2 / Phase 3 | 63 | National Cancer Institute (NCI)NIH | 5 | Apr 13, 2020 | clinicaltrials |
| NCT01077518 | Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy(A+B) | terminated | Phase 3 | 346 | Novartis PharmaceuticalsINDUSTRY | 17 | Mar 27, 2020 | clinicaltrials |
| NCT00354744 | High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | completed | Phase 3 | 109 | Children's Oncology GroupNETWORK | 5 | Jan 29, 2020 | clinicaltrials |
| NCT00897325 | Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma | completed | — | 811 | Children's Oncology GroupNETWORK | 5 | Jan 18, 2020 | clinicaltrials |
| NCT00281528 | Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer | terminated | Phase 2 | 208 | CelgeneINDUSTRY | 2 | Nov 22, 2019 | clinicaltrials |
| NCT01021423 | A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL).(RENEW) | terminated | Phase 3 | 9 | CelgeneINDUSTRY | 12 | Nov 19, 2019 | clinicaltrials |
| NCT00825955 | Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment(BRISK PS) | completed | Phase 3 | 587 | Bristol-Myers SquibbINDUSTRY | 19 | Oct 9, 2019 | clinicaltrials |
| NCT00690469 | Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers | completed | — | 234 | Children's Oncology GroupNETWORK | 3 | Oct 8, 2019 | clinicaltrials |
| NCT00694551 | PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment | completed | N/A | 29 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Oct 4, 2019 | clinicaltrials |
| NCT01490632 | A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis | completed | Phase 2 | 271 | Eli Lilly and CompanyINDUSTRY | 4 | Sep 27, 2019 | clinicaltrials |
| NCT01168973 | A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy | completed | Phase 3 | 1,253 | Eli Lilly and CompanyINDUSTRY | 27 | Sep 25, 2019 | clinicaltrials |
| NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | completed | Phase 3 | 1,072 | Eli Lilly and CompanyINDUSTRY | 26 | Sep 25, 2019 | clinicaltrials |
| NCT01721044 | A Moderate to Severe Rheumatoid Arthritis Study(RA-BEACON) | completed | Phase 3 | 527 | Eli Lilly and CompanyINDUSTRY | 22 | Sep 18, 2019 | clinicaltrials |
| NCT00087711 | A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer | completed | Phase 3 | 1,713 | Eli Lilly and CompanyINDUSTRY | 27 | Sep 12, 2019 | clinicaltrials |
| NCT03988114 | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer(proMONARCH) | withdrawn | Phase 4 | 0 | Eli Lilly and CompanyINDUSTRY | 9 | Sep 6, 2019 | clinicaltrials |
| NCT01322490 | A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer(Prospect) | completed | Phase 3 | 1,297 | Bavarian NordicINDUSTRY | 16 | Sep 4, 2019 | clinicaltrials |
| NCT00238264 | Radiation Therapy in Treating Young Patients With Gliomas | completed | Phase 2 | 92 | Children's Oncology GroupNETWORK | 6 | Aug 7, 2019 | clinicaltrials |
| NCT00004228 | Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma | completed | Phase 3 | 393 | Children's Oncology GroupNETWORK | 5 | Aug 6, 2019 | clinicaltrials |
| NCT01039376 | Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy(PROLONG) | terminated | Phase 3 | 480 | Novartis PharmaceuticalsINDUSTRY | 25 | Jul 30, 2019 | clinicaltrials |
| NCT02209532 | A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping(FILM) | completed | N/A | 180 | Novadaq Technologies ULC, now a part of StrykerINDUSTRY | 3 | Mar 25, 2019 | clinicaltrials |
| NCT02855359 | Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma | terminated | Phase 2 | 24 | Seagen Inc.INDUSTRY | 2 | Mar 11, 2019 | clinicaltrials |
| NCT00061893 | Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors | completed | Phase 2 | 38 | Children's Oncology GroupNETWORK | 4 | Feb 15, 2019 | clinicaltrials |
| NCT00513292 | Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery | completed | Phase 3 | 280 | National Cancer Institute (NCI)NIH | 2 | Jan 23, 2019 | clinicaltrials |
| NCT00876395 | Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer(BOLERO-1) | completed | Phase 3 | 719 | Novartis PharmaceuticalsINDUSTRY | 28 | Dec 19, 2018 | clinicaltrials |
| NCT00960440 | Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors | completed | Phase 3 | 399 | PfizerINDUSTRY | 14 | Dec 19, 2018 | clinicaltrials |
| NCT01258608 | Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 101 | Human Genome Sciences Inc., a GSK CompanyINDUSTRY | 7 | Dec 19, 2018 | clinicaltrials |
| NCT00869206 | Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement | completed | Phase 3 | 1,822 | Alliance for Clinical Trials in OncologyOTHER | 2 | Nov 7, 2018 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials